130 related articles for article (PubMed ID: 3259296)
1. Longitudinal studies of regional cerebral metabolism in Alzheimer's disease.
Jagust WJ; Friedland RP; Budinger TF; Koss E; Ober B
Neurology; 1988 Jun; 38(6):909-12. PubMed ID: 3259296
[TBL] [Abstract][Full Text] [Related]
2. Intercorrelations of regional cerebral glucose metabolic rates in Alzheimer's disease.
Horwitz B; Grady CL; Schlageter NL; Duara R; Rapoport SI
Brain Res; 1987 Mar; 407(2):294-306. PubMed ID: 3494486
[TBL] [Abstract][Full Text] [Related]
3. Cortical abnormalities in Alzheimer's disease.
Foster NL; Chase TN; Mansi L; Brooks R; Fedio P; Patronas NJ; Di Chiro G
Ann Neurol; 1984 Dec; 16(6):649-54. PubMed ID: 6335378
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization.
Friedland RP; Budinger TF; Koss E; Ober BA
Neurosci Lett; 1985 Feb; 53(3):235-40. PubMed ID: 3872424
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography in Alzheimer's disease.
Duara R; Grady C; Haxby J; Sundaram M; Cutler NR; Heston L; Moore A; Schlageter N; Larson S; Rapoport SI
Neurology; 1986 Jul; 36(7):879-87. PubMed ID: 3487046
[TBL] [Abstract][Full Text] [Related]
6. The effect of brain atrophy on cerebral hypometabolism in the visual variant of Alzheimer disease.
Bokde AL; Pietrini P; Ibáñez V; Furey ML; Alexander GE; Graff-Radford NR; Rapoport SI; Schapiro MB; Horwitz B
Arch Neurol; 2001 Mar; 58(3):480-6. PubMed ID: 11255453
[TBL] [Abstract][Full Text] [Related]
7. Decreased cortical glucose metabolism correlates with hippocampal atrophy in Alzheimer's disease as shown by MRI and PET.
Yamaguchi S; Meguro K; Itoh M; Hayasaka C; Shimada M; Yamazaki H; Yamadori A
J Neurol Neurosurg Psychiatry; 1997 Jun; 62(6):596-600. PubMed ID: 9219745
[TBL] [Abstract][Full Text] [Related]
8. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
Oh H; Madison C; Baker S; Rabinovici G; Jagust W
Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
[TBL] [Abstract][Full Text] [Related]
10. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
[TBL] [Abstract][Full Text] [Related]
11. Frontal lobe tasks do not reflect frontal lobe function in patients with probable Alzheimer's disease.
Kessler J; Mielke R; Grond M; Herholz K; Heiss WD
Int J Neurosci; 2000; 104(1-4):1-15. PubMed ID: 11011970
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneous anterior-posterior metabolic patterns in dementia of the Alzheimer type.
Haxby JV; Grady CL; Koss E; Horwitz B; Schapiro M; Friedland RP; Rapoport SI
Neurology; 1988 Dec; 38(12):1853-63. PubMed ID: 3194063
[TBL] [Abstract][Full Text] [Related]
13. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
Pietrini P; Dani A; Furey ML; Alexander GE; Freo U; Grady CL; Mentis MJ; Mangot D; Simon EW; Horwitz B; Haxby JV; Schapiro MB
Am J Psychiatry; 1997 Aug; 154(8):1063-9. PubMed ID: 9247390
[TBL] [Abstract][Full Text] [Related]
14. Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization.
Küntzelmann A; Guenther T; Haberkorn U; Essig M; Giesel F; Henze R; Schroeter ML; Schröder J; Schönknecht P
Neurosci Lett; 2013 Feb; 534():12-7. PubMed ID: 23182881
[TBL] [Abstract][Full Text] [Related]
15. Regional cortical dysfunction in Alzheimer's disease as determined by positron emission tomography.
Chase TN; Foster NL; Fedio P; Brooks R; Mansi L; Di Chiro G
Ann Neurol; 1984; 15 Suppl():S170-4. PubMed ID: 6611118
[TBL] [Abstract][Full Text] [Related]
16. Reductions in parietal and temporal cerebral metabolic rates for glucose are not specific for Alzheimer's disease.
Schapiro MB; Pietrini P; Grady CL; Ball MJ; DeCarli C; Kumar A; Kaye JA; Haxby JV
J Neurol Neurosurg Psychiatry; 1993 Aug; 56(8):859-64. PubMed ID: 8350100
[TBL] [Abstract][Full Text] [Related]
17. Coronal reconstruction images of glucose metabolism in Alzheimer's disease.
Fukuyama H; Harada K; Yamauchi H; Miyoshi T; Yamaguchi S; Kimura J; Kameyama M; Senda M; Yonekura Y; Konishi J
J Neurol Sci; 1991 Dec; 106(2):128-34. PubMed ID: 1802960
[TBL] [Abstract][Full Text] [Related]
18. Relation of EEG alpha background to parietal lobe function in Alzheimer's disease as measured by positron emission tomography and psychometry.
Sheridan PH; Sato S; Foster N; Bruno G; Cox C; Fedio P; Chase TN
Neurology; 1988 May; 38(5):747-50. PubMed ID: 3258970
[TBL] [Abstract][Full Text] [Related]
19. Association between brain functional failure and dementia severity in Alzheimer's disease: resting versus stimulation PET study.
Pietrini P; Furey ML; Alexander GE; Mentis MJ; Dani A; Guazzelli M; Rapoport SI; Schapiro MB
Am J Psychiatry; 1999 Mar; 156(3):470-3. PubMed ID: 10080567
[TBL] [Abstract][Full Text] [Related]
20. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.
Pietrini P; Furey ML; Graff-Radford N; Freo U; Alexander GE; Grady CL; Dani A; Mentis MJ; Schapiro MB
Am J Psychiatry; 1996 Oct; 153(10):1261-8. PubMed ID: 8831432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
